Search Results Search Sort by RelevanceMost Recent Podcast Dec 2019 Ethics Talk: How Do We Prepare for Human Gene Editing? Dr Sean C. McConnell provides an introduction to gene editing, and Scott J. Schweikart discusses what prudent governance requires. Health Law Jun 2005 A Physician's Role in Informing Family Members of Genetic Risk Faith Lagay, PhD Virtual Mentor. 2005;7(6):435-437. doi: 10.1001/virtualmentor.2005.7.6.hlaw1-0506. Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612. Case and Commentary Nov 2005 Partial Androgen Insensitivity Syndrome, Commentary 1 William G. Reiner, MD Virtual Mentor. 2005;7(11):739-742. doi: 10.1001/virtualmentor.2005.7.11.ccas3-0511. Case and Commentary Nov 2005 Partial Androgen Insensitivity Syndrome, Commentary 2 David A. Diamond, MD Virtual Mentor. 2005;7(11):742-744. doi: 10.1001/virtualmentor.2005.7.11.ccas3-0511. Case and Commentary Nov 2005 Partial Androgen Insensitivity Syndrome, Commentary 3 Tammy Camp, MD and Surendra K. Varma, MD Virtual Mentor. 2005;7(11):744-747. doi: 10.1001/virtualmentor.2005.7.11.ccas3-0511. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. History of Medicine Jul 2017 Framing Confusion: Dementia, Society, and History Jesse F. Ballenger, PhD, MA Viewing dementia as a distinct disease promotes funding for research but may stigmatize those who have dementia and lead to disinvestment in caregiving. AMA J Ethics. 2017;19(7):713-719. doi: 10.1001/journalofethics.2017.19.7.mhst1-1707. Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Podcast Dec 2019 Ethics Talk: How Do We Prepare for Human Gene Editing? Dr Sean C. McConnell provides an introduction to gene editing, and Scott J. Schweikart discusses what prudent governance requires.
Health Law Jun 2005 A Physician's Role in Informing Family Members of Genetic Risk Faith Lagay, PhD Virtual Mentor. 2005;7(6):435-437. doi: 10.1001/virtualmentor.2005.7.6.hlaw1-0506.
Health Law Dec 2016 The Legal Implications of Detecting Alzheimer’s Disease Earlier Joshua Preston, Jaleh McTeigue, Caitlin Opperman, Jordan Dean Scott Krieg, Mikaela Brandt-Fontaine, Alina Yasis, and Francis X. Shen, JD, PhD What are insurance, contract, and criminal law implications of detecting Alzheimer’s disease early? AMA J Ethics. 2016;18(12):1207-1217. doi: 10.1001/journalofethics.2016.18.12.hlaw1-1612.
Case and Commentary Nov 2005 Partial Androgen Insensitivity Syndrome, Commentary 1 William G. Reiner, MD Virtual Mentor. 2005;7(11):739-742. doi: 10.1001/virtualmentor.2005.7.11.ccas3-0511.
Case and Commentary Nov 2005 Partial Androgen Insensitivity Syndrome, Commentary 2 David A. Diamond, MD Virtual Mentor. 2005;7(11):742-744. doi: 10.1001/virtualmentor.2005.7.11.ccas3-0511.
Case and Commentary Nov 2005 Partial Androgen Insensitivity Syndrome, Commentary 3 Tammy Camp, MD and Surendra K. Varma, MD Virtual Mentor. 2005;7(11):744-747. doi: 10.1001/virtualmentor.2005.7.11.ccas3-0511.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
History of Medicine Jul 2017 Framing Confusion: Dementia, Society, and History Jesse F. Ballenger, PhD, MA Viewing dementia as a distinct disease promotes funding for research but may stigmatize those who have dementia and lead to disinvestment in caregiving. AMA J Ethics. 2017;19(7):713-719. doi: 10.1001/journalofethics.2017.19.7.mhst1-1707.
Viewpoint Dec 2016 Changing Memories: Between Ethics and Speculation Eric Racine, PhD and William Affleck Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts. AMA J Ethics. 2016;18(12):1241-1248. doi: 10.1001/journalofethics.2016.18.12.sect1-1612.